Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery
Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery
About this item
Full title
Author / Creator
Publisher
New York, NY: Mosby, Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Mosby, Inc
Subjects
More information
Scope and Contents
Contents
Background Heparin-induced thrombocytopenia (HIT) is caused by anti–platelet factor 4/heparin (PF4/H) immunoglobulin (Ig) G antibodies, which activate platelets. In some patients, anti-PF4/H antibodies are already detectable before cardiac surgery. Whether preoperative presence of antibodies confers adverse prognosis and which particular antibody c...
Alternative Titles
Full title
Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_748956635
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_748956635
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2010.05.026
